Novo Nordisk A/S (NVO)
126.26
-2.38
(-1.85%)
USD |
NYSE |
Apr 24, 14:43
Novo Nordisk Total Long Term Debt (Quarterly): 3.159B for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.159B |
September 30, 2023 | 3.758B |
June 30, 2023 | 3.751B |
March 31, 2023 | 3.735B |
December 31, 2022 | 3.059B |
September 30, 2022 | 3.432B |
June 30, 2022 | 3.571B |
March 31, 2022 | 3.824B |
December 31, 2021 | 3.428B |
September 30, 2021 | 2.145B |
June 30, 2021 | 2.203B |
March 31, 2021 | 1.522B |
December 31, 2020 | 1.105B |
September 30, 2020 | 647.09M |
June 30, 2020 | 624.99M |
March 31, 2020 | 606.99M |
December 31, 2019 | 98.80M |
September 30, 2019 | 636.42M |
June 30, 2019 | 644.72M |
March 31, 2019 | 648.91M |
December 31, 2018 | 78.89M |
September 30, 2018 | 52.43M |
June 30, 2018 | 38.31M |
March 31, 2018 | 37.69M |
December 31, 2017 | 272.99M |
Date | Value |
---|---|
September 30, 2017 | 41.15M |
June 30, 2017 | 258.90M |
March 31, 2017 | 88.06M |
December 31, 2016 | 32.57M |
September 30, 2016 | 68.63M |
June 30, 2016 | 60.71M |
March 31, 2016 | 61.73M |
December 31, 2015 | 157.17M |
September 30, 2015 | 95.03M |
June 30, 2015 | 110.64M |
March 31, 2015 | 86.11M |
December 31, 2014 | 117.55M |
September 30, 2014 | 48.41M |
June 30, 2014 | 74.28M |
March 31, 2014 | 148.04M |
December 31, 2013 | 39.79M |
September 30, 2013 | 121.22M |
June 30, 2013 | 125.11M |
March 31, 2013 | 51.56M |
December 31, 2012 | 88.62M |
September 30, 2012 | 188.91M |
June 30, 2012 | 148.95M |
March 31, 2012 | 159.98M |
December 31, 2011 | 148.64M |
September 30, 2011 | 400.43M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
98.80M
Minimum
Dec 2019
3.824B
Maximum
Mar 2022
2.208B
Average
2.203B
Median
Jun 2021
Total Long Term Debt (Quarterly) Benchmarks
Amgen Inc | 64.61B |
AstraZeneca PLC | 27.49B |
Sanofi SA | 18.12B |
Viking Therapeutics Inc | -- |
Evaxion Biotech AS | 8.648M |